Goldline Pharmaceutical Ltd., established in 2004, operates in the Pharmaceuticals sector. The company's IPO will open on May 12, 2026 and close on May 14, 2026, with an issue price of ₹43. The ... Read more
| Investors Category | Shares Offered |
|---|---|
| Anchor Investors | 7,32,000 (27.11%) |
| Market Makers | 1,38,000 (5.11%) |
| Non Institutional Investors | 3,90,000 (14.44%) |
| Qualified Institutional Buyers (QIBs) | 5,40,000 (20%) |
| Retail Individual Investors (RIIs) | 9,00,000 (33.33%) |
| Year End | Revenue | PAT | Reserves & Surplus |
|---|---|---|---|
| 31 Mar 2025 | 28.06 Cr | 2.83 Cr | 1.64 Cr |
| 31 Mar 2024 | 23.57 Cr | 1.80 Cr | 3.76 Cr |
| 31 Mar 2023 | 19.85 Cr | 25.66 Lakh | 2.08 Cr |
When does Goldline Pharmaceutical Ltd. IPO opens and closes?
What is the size of Goldline Pharmaceutical Ltd. IPO?
What is the price range of Goldline Pharmaceutical Ltd. IPO?
What is the minimum investment and lot size required for the Goldline Pharmaceutical Ltd. IPO?
When is Goldline Pharmaceutical Ltd. IPO listing date?
Who are the book runners for Goldline Pharmaceutical Ltd. IPO?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article